Published in Ann Rheum Dis on June 01, 1957
Circadian rhythms in RA. Ann Rheum Dis (2003) 1.47
The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem (1954) 9.34
Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine. Lancet (1953) 9.28
A method for the determination of 17-hydroxycorticosteroids in blood; 17-hydroxycorticosterone in the peripheral circulation. J Clin Endocrinol Metab (1952) 6.85
A quantitative color reaction for cortisone and related 17,21-dihydroxy-20-ketosteroids. J Biol Chem (1950) 4.77
The fate of hydrocortisone-4-C14 in man. J Clin Invest (1954) 4.21
Adrenocortical hormones in human plasma. J Biol Chem (1953) 3.84
Modification of the Reddy-Jenkins-Thorn method for the estimation of 17-hydroxycorticoids in urine. Metabolism (1954) 2.67
A chromatographic investigation of alpha 4-3-ketosteroids and alpha-ketolic steroids in human urine. J Endocrinol (1953) 2.11
Simulated adreno-cortical activity during pregnancy in an Addisonian patient. J Clin Invest (1950) 1.98
Binding of corticosteroids by plasma proteins. I. Dialysis equilibrium and renal clearance studies. J Clin Invest (1956) 1.90
The binding of steroids to protein. I. Solubility determinations. J Biol Chem (1954) 1.89
Blood levels of 17-hydroxycorticosteroids in normal pregnancy. J Clin Endocrinol Metab (1953) 1.63
Metabolism of 4-C 14-cortisol in man: body distribution and rates of conjugation. J Clin Endocrinol Metab (1956) 1.57
The effect of intravenously-administered ACTH on plasma 17,21-dihydroxy-20-ketosteroids in normal individuals and in patients with disorders of the adrenal cortex. J Clin Invest (1955) 1.37
Tracer studies of the absorption and fate of steroid hormones in man. J Clin Invest (1956) 1.29
A note of caution on the lack of specificity of the Porter-Silber reaction for 17,21-dihydroxy-20-ketosteroids. J Clin Endocrinol Metab (1954) 1.27
The polarographic estimation of steroid hormones. VI. Determination of individual adrenocortical hormones in human peripheral blood. Biochem J (1953) 1.26
Placental passage of 17-hydroxycorticosteroids: comparison of the levels in maternal and fetal plasma and effect of ACTH and hydrocortisone administration. J Clin Invest (1956) 1.20
The fate of C14 testosterone and C14-progesterone in mice and rats. Endocrinology (1952) 1.16
Levels of 17-hydroxycorticosteroids in body fluids. J Lab Clin Med (1954) 1.14
Observations during ACTH and cortisone administration to a patient with longstanding panhypopituitarism and rheumatoid arthritis. J Clin Invest (1951) 1.10
Acid-hydrolyzable corticoids of serum. J Clin Endocrinol Metab (1955) 1.05
17,21-Dihydroxy-20-ketosteroids in plasma during and after pregnancy. J Clin Endocrinol Metab (1955) 1.04
Adrenocorticosteroids in peripheral and adrenal venous blood of man. J Clin Endocrinol Metab (1955) 1.01
An improved procedure for the determination of hydrocortisone in human plasma. J Clin Endocrinol Metab (1956) 0.97
Pregnancy and adrenocortical function; endocrine studies of pregnancy occurring in two adrenal-deficient women. J Clin Invest (1954) 0.95
Determination in plasma of free 17-hydroxy and 17-desoxy corticosteroids and their glucuronic-acid conjugates. J Clin Endocrinol Metab (1955) 0.95
Arthritis and panhypopituitarism. J Clin Endocrinol Metab (1953) 0.95
Metabolites of hydrocortisone and cortisone in synovial fluid in rheumatoid arthritis. J Clin Endocrinol Metab (1956) 0.94
Studies of cerebrospinal fluid following oral administration of cortisone acetate or hydrocortisone. J Endocrinol (1955) 0.91
The excretion pattern of 17-ketosteroids and corticosteroids in surgical stress. Acta Endocrinol (Copenh) (1955) 0.91
Lack of secretion of 17-hydroxycorticosteroids in a pregnant woman with Addison's disease. J Clin Endocrinol Metab (1956) 0.80
Atypical Porter-Silber reaction after the administration of sulfamerazine. J Clin Endocrinol Metab (1955) 0.79
The biosynthesis of adrenal steroids. Ann N Y Acad Sci (1955) 0.78
Improved estimation of the urinary 17, 21-dihydroxy-20-keto-steroids by use of the Allen correction in the method of Reddy. Acta Endocrinol (Copenh) (1955) 0.77
Effects of aldosterone (electrocortin), 9-alpha-fluorohydrocortisone acetate, and 1-dehydrocortisone (metacortandracin) in rheumatoid arthritis. Ann N Y Acad Sci (1955) 0.77
The physiological disposition and metabolic fate of hydrocortisone in man. Ann N Y Acad Sci (1955) 0.77
Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine. Lancet (1953) 9.28
Cortisone and rheumatoid disease. Lancet (1953) 4.11
Effects of prolonged adrenocortical stimulation on patients with rheumatoid arthritis. Ann Rheum Dis (1957) 3.05
Prevention of peptic ulceration during corticosteroid therapy. Br Med J (1959) 1.78
Acquired resistance to corticotropins. Ann Rheum Dis (1956) 1.62
Treatment of rheumatoid arthritis by prolonged stimulation of the adrenal cortex. Lancet (1955) 1.58
Oral prednisolone phosphate therapy. Arch Dis Child (1963) 1.37
Relation of free corticosteroids in urine to steroid dosage. Lancet (1960) 1.32
Corticosteroid therapy in childhood. Lancet (1961) 1.30
Some effects of long-continued cortisone therapy in rheumatoid arthritis. Lancet (1952) 1.12
Ankylosing spondylitis and prolonged ACTH therapy. Ann Rheum Dis (1954) 1.01
Use of the intramuscular route for prednisolone acetate therapy. Ann Rheum Dis (1958) 0.99
Functional and vocational recovery in severe poliomyelitis. Clin Orthop (1958) 0.99
Corticosteroid bruising. Ann Rheum Dis (1961) 0.97
Ten years of ACTH therapy. Ann Rheum Dis (1962) 0.94
HYDROCORTISONE METABOLISM. Lancet (1964) 0.90
Long-term intramuscular prednisolone therapy. Ann Rheum Dis (1962) 0.85
SOME ASPECTS OF THE METABOLISM AND DISPOSITION OF BETAMETHASONE. Acta Endocrinol (Copenh) (1964) 0.85
Cortisol and cortisone in saliva of pregnancy. J Endocrinol (1963) 0.81
Trials of cortisone analogues in the treatment of rheumatoid arthritis. Ann Rheum Dis (1959) 0.79
CIRCULATING AND RESPIRATORY STUDIES IN MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK. Lancet (1964) 0.78
Heart disease in the case-finding program. Am Rev Tuberc (1946) 0.76
Purified ACTH gel control of therapy in rheumatoid patients. Ann Rheum Dis (1954) 0.76
Effects of 9-alpha-fluoro hydrocortisone acetate on adrenal function. Ann Rheum Dis (1955) 0.75
16-METHYLENE-PREDNISOLONE: ADRENAL SUPPRESSION SHOWN BY GAS-CHROMATOGRAPHY. Lancet (1963) 0.75
Ankylosing spondylitis. Med Illus (1955) 0.75
Ankylosing spondylitis. Br Med J (1949) 0.75
Corticosteroid therapy for rheumatoid arthritis. Some practical and theoretical observations. Acta Rheumatol Scand (1962) 0.75
Protein metabolism during corticosteroid therapy. Lancet (1958) 0.75
Adrenocorticotropins and their use. Acta Med Scand Suppl (1960) 0.75
Corticosteroid metabolism and the rheumatic diseases. Practitioner (1958) 0.75
The nature of the corticosteroid effect in rheumatoid arthritis. Lancet (1962) 0.75
Cortisone acetate v. cortisol in the treatment of rheumatoid disease. Lancet (1954) 0.75
RAPID SCREENING TEST FOR ADRENAL CORTICAL FUNCTION. Lancet (1964) 0.75
Rabelais, Sterne and Osler: companions in wit. Trans Stud Coll Physicians Phila (1959) 0.75